Second generation human papillomavirus (HPV) vaccine for broad-spectrum protection against HPV-induced skin and mucosal neoplasia
Duration: 60 months, Funding volume: € 800,000
Tumor-infiltrating CD20+ B cells: Promoters of human melanoma?
Duration: 60 months, Funding volume: € 767,400